DK1601792T3 - Fremgangsmåde til identifikation af kolo-rektale tumorer - Google Patents

Fremgangsmåde til identifikation af kolo-rektale tumorer

Info

Publication number
DK1601792T3
DK1601792T3 DK04715277.2T DK04715277T DK1601792T3 DK 1601792 T3 DK1601792 T3 DK 1601792T3 DK 04715277 T DK04715277 T DK 04715277T DK 1601792 T3 DK1601792 T3 DK 1601792T3
Authority
DK
Denmark
Prior art keywords
colo
identifying
rectal tumors
rectal
tumors
Prior art date
Application number
DK04715277.2T
Other languages
English (en)
Inventor
Daniele Calistri
Claudia Rengucci
Original Assignee
Istituto Oncologico Romagnolo Cooperativa Sociale A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Oncologico Romagnolo Cooperativa Sociale A R L filed Critical Istituto Oncologico Romagnolo Cooperativa Sociale A R L
Application granted granted Critical
Publication of DK1601792T3 publication Critical patent/DK1601792T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04715277.2T 2003-03-07 2004-02-27 Fremgangsmåde til identifikation af kolo-rektale tumorer DK1601792T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000434A ITMI20030434A1 (it) 2003-03-07 2003-03-07 Metodo per l'individuazione di tumori del colon-retto.
PCT/EP2004/001997 WO2004079004A1 (en) 2003-03-07 2004-02-27 Method for the identification of colorectal tumors

Publications (1)

Publication Number Publication Date
DK1601792T3 true DK1601792T3 (da) 2011-01-24

Family

ID=32948201

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04715277.2T DK1601792T3 (da) 2003-03-07 2004-02-27 Fremgangsmåde til identifikation af kolo-rektale tumorer

Country Status (12)

Country Link
US (1) US8343722B2 (da)
EP (1) EP1601792B1 (da)
AT (1) ATE491040T1 (da)
CA (1) CA2517983C (da)
CY (1) CY1111149T1 (da)
DE (1) DE602004030427D1 (da)
DK (1) DK1601792T3 (da)
ES (1) ES2355559T3 (da)
IT (1) ITMI20030434A1 (da)
PT (1) PT1601792E (da)
SI (1) SI1601792T1 (da)
WO (1) WO2004079004A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
GB9410922D0 (en) * 1994-06-01 1994-07-20 Townsend Alain R M Vaccines
US6482803B1 (en) * 1995-09-01 2002-11-19 Board Of Regents, The University Of Texas System Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
US6630301B1 (en) 1997-03-14 2003-10-07 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
US5811239A (en) * 1996-05-13 1998-09-22 Frayne Consultants Method for single base-pair DNA sequence variation detection
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6143529A (en) 1996-08-14 2000-11-07 Exact Laboratories, Inc. Methods for improving sensitivity and specificity of screening assays
US5723298A (en) * 1996-09-16 1998-03-03 Li-Cor, Inc. Cycle labeling and sequencing with thermostable polymerases
AU8776898A (en) 1997-08-04 1999-02-22 Oncormed, Inc. Determining common functional alleles in a population and uses therefor
US20020004206A1 (en) 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
JP2001128685A (ja) 1999-11-05 2001-05-15 Iatron Lab Inc ヒトｐ５３遺伝子の変異の検出方法
US6919174B1 (en) * 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
EP1268768A2 (en) 2000-03-27 2003-01-02 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides

Also Published As

Publication number Publication date
CA2517983A1 (en) 2004-09-16
CY1111149T1 (el) 2015-06-11
ITMI20030434A1 (it) 2004-09-08
EP1601792B1 (en) 2010-12-08
ES2355559T3 (es) 2011-03-28
ATE491040T1 (de) 2010-12-15
US8343722B2 (en) 2013-01-01
CA2517983C (en) 2013-09-17
EP1601792A1 (en) 2005-12-07
PT1601792E (pt) 2011-02-04
WO2004079004A1 (en) 2004-09-16
DE602004030427D1 (de) 2011-01-20
SI1601792T1 (sl) 2011-02-28
US20060216713A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
WO2006113466A8 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2006015742A3 (de) Tumormarker zur diagnose von kolorektalen karzinomen und/oder davon abstammender metastasen
AU2004205878A8 (en) Gene expression markers for breast cancer prognosis
IL162722A0 (en) Method for detecting human papillomarirus mrna
WO2004030511A3 (en) Prostate cancer biomarkers
WO2008130887A8 (en) Biomarkers for follicular thyroid carcinoma and methods of of use
EP1572100A4 (en) USEFUL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANGIOGENESIS MODULATION, METASTASIS AND TUMOR FIBROSIS INHIBITION, AND EVALUATION OF THE MALIGNANCE OF THICK CARCINOMAS
DK1812590T3 (da) Fremgangsmåder og reagenser til detektering af melanomer
DK1994410T3 (da) Fremgangsmåder og kits til tidlig påvisning af cancer eller disposition derfor
ATE455853T1 (de) Antikörper gegen geschädigtes gewebe
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2005001141A3 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO2006110594A3 (en) Sema4d in cancer diagnosis, detection and treatment
DK1601792T3 (da) Fremgangsmåde til identifikation af kolo-rektale tumorer
WO2008061527A3 (de) Prognostische marker für die klassifizierung von kolorektalen karzinomen basierend auf expressionsprofilen von biologischen proben
WO2005030788A3 (de) Verfahren zur nichtinvasiven früherkennung von dickdarmkrebs und/oder darmkrebsvorläuferzellen
NO20052628L (no) Nye pyrimidin-4,6-dikarboksamider for selektiv inhibering av kollagenaser
WO2005001140A3 (en) Methods and nucleic acids for the analysis of colon cell proliferative disorders
WO2007115213A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2004096021A3 (en) Global analysis of transposable elements as molecular markers of cancer
WO2004001016A3 (en) Methods for detection of genetic alterations associated with cancer
EP1741793A4 (en) HYBRIDIZATION PROCESS
EP1604032A4 (en) Method for detecting prognosis of cancer
WO2008112154A3 (en) Methods of using genomic biomarkers to predict tumor formation
WO2004038366A3 (en) ISOTHERMAL AMPLIFICATION BASED ASSAY FOR THE DETECTION AND QUANTITATION OF ALPHA-FETOPROTEIN mRNA